99 related articles for article (PubMed ID: 6828317)
1. [NK (natural killer) and K (killer) cell activity in breast cancer. Relation of the stage of the disease to cytotoxic activity].
Garam T; Bakács T; Tótpál K; Svastits E; Ringwald G; Petrányi G
Orv Hetil; 1983 Jan; 124(1):15-8. PubMed ID: 6828317
[No Abstract] [Full Text] [Related]
2. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
3. [Functional activity of the natural killers and macrophages in patients with breast tumors].
Andrianov IG; Voronov SM; Dobkin AN; Okulov VB; Orlov AB
Vopr Onkol; 1988; 34(12):1455-60. PubMed ID: 3265236
[TBL] [Abstract][Full Text] [Related]
4. Stage dependence of NK cell activity and its modulation by interleukin 2 in patients with breast cancer.
Konjević G; Spuzić I
Neoplasma; 1993; 40(2):81-5. PubMed ID: 8350959
[TBL] [Abstract][Full Text] [Related]
5. [The effect of autoplasma of patients with breast cancer on the functional activity of natural killer cells and adhering mononuclear cells in peripheral blood in vitro].
Andrianov IG; Katashkova TN
Eksp Onkol; 1989; 11(5):64-6. PubMed ID: 2791959
[TBL] [Abstract][Full Text] [Related]
6. Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.
Arteaga CL; Hurd SD; Winnier AR; Johnson MD; Fendly BM; Forbes JT
J Clin Invest; 1993 Dec; 92(6):2569-76. PubMed ID: 7504687
[TBL] [Abstract][Full Text] [Related]
7. Influence of a moderate exercise training on natural killer cytotoxicity and personality traits in cancer patients.
Peters C; Lötzerich H; Niemeier B; Schüle K; Uhlenbruck G
Anticancer Res; 1994; 14(3A):1033-6. PubMed ID: 8074446
[TBL] [Abstract][Full Text] [Related]
8. Moderate exercise training and natural killer cell cytotoxic activity in breast cancer patients.
Nieman DC; Cook VD; Henson DA; Suttles J; Rejeski WJ; Ribisl PM; Fagoaga OR; Nehlsen-Cannarella SL
Int J Sports Med; 1995 Jul; 16(5):334-7. PubMed ID: 7558532
[TBL] [Abstract][Full Text] [Related]
9. [Immunomodulating activity of natural killers in patients with breast tumors using vasopressin and interleukin 2 in vitro].
Andrianov IG; Dobkin AN; Kiselev OI; Okulov VB; Semiglazov VF
Vopr Onkol; 1989; 35(10):1186-91. PubMed ID: 2596062
[TBL] [Abstract][Full Text] [Related]
10. Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activity.
Miller JS; Tessmer-Tuck J; Pierson BA; Weisdorf D; McGlave P; Blazar BR; Katsanis E; Verfaillie C; Lebkowski J; Radford J; Burns LJ
Biol Blood Marrow Transplant; 1997 Apr; 3(1):34-44. PubMed ID: 9209739
[TBL] [Abstract][Full Text] [Related]
11. Suppression of natural killer cell activity by serum derived from head and neck cancer patients.
Kumazawa H; Minamino M; Yukawa N; Hess M
Cancer Detect Prev; 1995; 19(6):494-502. PubMed ID: 8925518
[TBL] [Abstract][Full Text] [Related]
12. Immune responses to guided imagery during breast cancer treatment.
Lengacher CA; Bennett MP; Gonzalez L; Gilvary D; Cox CE; Cantor A; Jacobsen PB; Yang C; Djeu J
Biol Res Nurs; 2008 Jan; 9(3):205-14. PubMed ID: 18077773
[TBL] [Abstract][Full Text] [Related]
13. Circulating killer cells in women undergoing needle-directed excisional breast biopsy.
Ohlsson-Wilhelm BM; Wang G
Eur J Histochem; 1994; 38 Suppl 1():77-82. PubMed ID: 8547715
[TBL] [Abstract][Full Text] [Related]
14. Defective natural killer (NK) and killer (K) cell function in systemic lupus erythematosus.
Ewan PW; Barrett HM; Pusey CD
J Clin Lab Immunol; 1983 Feb; 10(2):71-6. PubMed ID: 6842577
[TBL] [Abstract][Full Text] [Related]
15. Natural killer cell activity in endometriosis: correlation between serum estradiol levels and cytotoxicity.
Garzetti GG; Ciavattini A; Provinciali M; Fabris N; Cignitti M; Romanini C
Obstet Gynecol; 1993 May; 81(5 ( Pt 1)):665-8. PubMed ID: 8469451
[TBL] [Abstract][Full Text] [Related]
16. Increase of regulatory T cells in the peripheral blood of cancer patients.
Wolf AM; Wolf D; Steurer M; Gastl G; Gunsilius E; Grubeck-Loebenstein B
Clin Cancer Res; 2003 Feb; 9(2):606-12. PubMed ID: 12576425
[TBL] [Abstract][Full Text] [Related]
17. IL-2 receptors, NK and LAK cytotoxicity of lymphocytes in breast carcinoma during prolonged thymopentin therapy.
Mazzarino C; Nicosia A; Monte V; Petralia S; Garraffo C; Girlando A; Santoro S; Malaponte G
J Nucl Med Allied Sci; 1990; 34(4 Suppl):161-2. PubMed ID: 2128707
[No Abstract] [Full Text] [Related]
18. Decreased natural killer cytotoxic activity in chronic alcoholism is associated with alcohol liver disease but not active ethanol consumption.
Laso FJ; Madruga JI; Girón JA; López A; Ciudad J; San Miguel JF; Alvarez-Mon M; Orfao A
Hepatology; 1997 May; 25(5):1096-100. PubMed ID: 9141423
[TBL] [Abstract][Full Text] [Related]
19. [Steroid receptors and NK cell activity in patients with breast cancer].
Konjević G; Branković-Magić M; Nikolić-Vukosavljević D; Spuzić I
Srp Arh Celok Lek; 1994; 122(5-6):139-42. PubMed ID: 17977410
[TBL] [Abstract][Full Text] [Related]
20. Targeting of natural killer cells to mammary carcinoma via naturally occurring tumor cell-bound iC3b and beta-glucan-primed CR3 (CD11b/CD18).
Vetvicka V; Thornton BP; Wieman TJ; Ross GD
J Immunol; 1997 Jul; 159(2):599-605. PubMed ID: 9218574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
